Healthcare Stocks: 2 To Buy, 1 To Avoid
Investors traditionally think of healthcare stocks as being highly defensive, due to the old adage: medical care is always needed, even in a bad economy. In recent years, though, the sector has become...
Hedge Fund - Visium Asset Management
Jacob Gottlieb Bio, Returns, Net Worth
Manager biograhy is currently missing.
Fund Profile
Showing:
| Fund Name: | Visium Asset Management |
| Manager | Jacob Gottlieb |
| Portfolio Value | $2,333,480,000 |
| Change This QTR | +0.83% |
Top Holdings
Showing:
Sorted by:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1.) | GILD | 4,091,264 | $167,455 | +278% |
7.17% | |
| 2.) | MRX | 3,850,000 | $128,013 | -4% |
5.48% | |
| 3.) | ENDP | 3,460,000 | $119,474 | +73% |
5.11% | |
| 4.) | AGN | 1,250,000 | $109,675 | +19% |
4.7% | |
| 5.) | VRX | 2,325,000 | $108,554 | +1450% |
4.65% | |
| 6.) | CVS | 2,110,000 | $86,046 | -38% |
3.68% | |
| 7.) | Grifols Sa |
12,727,801 | $70,385 | +69% |
3.01% | |
| 8.) | CAH | 1,411,677 | $57,328 | +2136% |
2.45% | |
| 9.) | VRUS | 426,300 | $54,652 | +19% |
2.34% | |
| 10.) | MRK | 1,258,000 | $47,427 |  |
2.03% | |
| 11.) | AMT | 716,300 | $42,985 | +2765% |
1.84% | |
| 12.) | RAI | 950,000 | $39,349 | |
1.68% | |
| 13.) | AMLN | 43,339,000 | $38,897 | +153% |
1.66% | |
| 14.) | PCYC | 2,313,300 | $34,283 | +19% |
1.46% | |
| 15.) | Lorillard IncCALL |
LO | 293,600 | $33,470 | +47% |
1.43% |
| 16.) | MDRX | 1,650,000 | $31,251 | +340% |
1.33% | |
| 17.) | BIIB | 277,101 | $30,495 | +1509% |
1.3% | |
| 18.) | CMED | 45,935,000 | $28,020 | |
1.2% | |
| 19.) | ONXX | 638,736 | $28,072 | -9% |
1.2% | |
| 20.) | HUM | 302,671 | $26,517 | |
1.13% |
News, Interviews and Investor Letters
PepsiCo Beat Q1 Analyst Estimates, But is it Worth the Investment?
PepsiCo (PEP) trumped analyst estimates on Thursday, April 26 when the company announced that during the first quarter 2012 it had earned 69 cents a share, over analyst estimates of 67 cents a share and...
Amylin Rejected $3.5 billion Bid from Bristol-Myers Squibb
Bloomberg reported this morning that Bristol-Squibb Myers (NYSE: BMY) approached Amylin (NASDSAQ: AMLN) with a $3.5 billion offer or $22 per share. The headlines indicate that the bid was rejected and...
Decoding Biotech and Finding Opportunity in Gilead $GILD
Biotechnology stocks have been on an upswing lately, pushing the iShares Nasdaq Biotechnology Index up roughly 20 percent through the first two months of the year – returning more than twice as much...
Hedge Fund Performance January 2012
HSBC published the Hedge Weekly for the week of Jan 30 to Feb 3, revealing a list of hedge funds’ performances in January 2012. Some of the hedge funds haven't reported any 2012 returns yet. Overall...
Hedge Fund Returns In 2011
HSBC published the Hedge Weekly #53, revealing a list of hedge funds’ return in 2011. The report didn't have some of the hedge funds Insider Monkey is tracking, so we updated those returns. Some of...
Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT). According to a regulatory filing, now RA Capital Management has 2.62 million shares in the stock. RA Capital...
Hedge Funds Make Tons Of Money After CVS Boosted Dividend
CVS Caremark Corporation (CVS) surges 7.66% at 11:47AM EST on Tuesday after the company revealed it would boost its quarterly dividend by about 30%. It seems that Cramer is right about CVS on Friday....
Hedge Funds Lose Big After United States Steel Corp Dropped 7.62%
United States Steel Corporation (X) dropped $7.62% at 3:28PM EST on Monday following other steel stocks. The entire industry is under pressure today after Schnitzer Steel Industries (SCHN) disclosed a...
D. E. Shaw Loses Big After InterMune Drops 18%
InterMune Inc. (ITMN) drops 18.64% at 2:05PM EST today. The stock is trading at $14.88 with unusually high volume on Thursday, down $3.41 from the close on Wednesday, corresponding to a 18.64% decline...
Hedge Fund Performance In November
Hedge fund performance in November 2011 was more disappointing than any time since the bankruptcy of Lehman Brothers. Hedge funds have failed to deliver impressive returns, and it becomes more difficult...
Seth Klarman’s Baupost Group Initiated New Passive Stake In Targacept Inc. (TRGT)
Seth Klarman’s Baupost Group disclosed on December 9th that the firm has initiated a 5.65 million shares brand new position in Targacept Inc. (TRGT), which gives the firm 16.92% passive stake in the...
Hedge Funds Make Big After $PLL Rises 8%
Pall Corporation (PLL) rose nearly 8% in trading on Friday after the company reported increases in revenue and adjusted earnings, which beat analyst expectations. Although the company’s first quarter...
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th. According to the filing, Orbimed Advisors sold 52 thousand shares in ANTH from...
5 Healthcare Stocks Rated Buy – $MSA, $CMN, $ZOLL, $QCOR, $EBS
Analyst recommendations can be a first step to determining if a stock is worth risking your hard-earned money. At any given time, there are thousands of stocks being recommended, and each for different...
